Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.455
-0.045 (-1.80%)
Oct 8, 2025, 1:58 PM EDT - Market open

Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $564.36 million. The enterprise value is $548.52 million.

Market Cap564.36M
Enterprise Value 548.52M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

Gossamer Bio has 229.88 million shares outstanding. The number of shares has increased by 4.01% in one year.

Current Share Class 229.88M
Shares Outstanding 229.88M
Shares Change (YoY) +4.01%
Shares Change (QoQ) +0.20%
Owned by Insiders (%) 3.56%
Owned by Institutions (%) 61.44%
Float 185.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 14.09
Forward PS 20.96
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 13.63
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.40

Current Ratio 4.40
Quick Ratio 4.11
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -13.28

Financial Efficiency

Return on equity (ROE) is -783.37% and return on invested capital (ROIC) is -41.64%.

Return on Equity (ROE) -783.37%
Return on Assets (ROA) -29.63%
Return on Invested Capital (ROIC) -41.64%
Return on Capital Employed (ROCE) -77.74%
Revenue Per Employee $277,497
Profits Per Employee -$956,848
Employee Count145
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax -3.54M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +135.71% in the last 52 weeks. The beta is 1.95, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y) 1.95
52-Week Price Change +135.71%
50-Day Moving Average 2.50
200-Day Moving Average 1.50
Relative Strength Index (RSI) 43.86
Average Volume (20 Days) 4,075,650

Short Selling Information

The latest short interest is 23.99 million, so 10.44% of the outstanding shares have been sold short.

Short Interest 23.99M
Short Previous Month 22.05M
Short % of Shares Out 10.44%
Short % of Float 12.95%
Short Ratio (days to cover) 5.60

Income Statement

In the last 12 months, Gossamer Bio had revenue of $40.24 million and -$138.74 million in losses. Loss per share was -$0.61.

Revenue40.24M
Gross Profit 40.24M
Operating Income -145.62M
Pretax Income -142.29M
Net Income -138.74M
EBITDA -145.29M
EBIT -145.62M
Loss Per Share -$0.61
Full Income Statement

Balance Sheet

The company has $212.92 million in cash and $202.83 million in debt, giving a net cash position of $10.09 million or $0.04 per share.

Cash & Cash Equivalents 212.92M
Total Debt 202.83M
Net Cash 10.09M
Net Cash Per Share $0.04
Equity (Book Value) -46.11M
Book Value Per Share -0.20
Working Capital 182.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$154.30 million and capital expenditures -$79,000, giving a free cash flow of -$154.38 million.

Operating Cash Flow -154.30M
Capital Expenditures -79,000
Free Cash Flow -154.38M
FCF Per Share -$0.67
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -361.91%
Pretax Margin -353.62%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.01%
Shareholder Yield -4.01%
Earnings Yield -24.84%
FCF Yield -27.64%

Analyst Forecast

The average price target for Gossamer Bio is $8.60, which is 250.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.60
Price Target Difference 250.31%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 27.89%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Gossamer Bio has an Altman Z-Score of -8.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.25
Piotroski F-Score n/a